These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33281824)

  • 1. Development of Patient-Derived Human Monoclonal Antibodies Against Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus 2 for Coronavirus Disease 2019 Diagnosis.
    Zhang L; Zheng B; Gao X; Zhang L; Pan H; Qiao Y; Suo G; Zhu F
    Front Immunol; 2020; 11():595970. PubMed ID: 33281824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralizing Human Antibodies against Severe Acute Respiratory Syndrome Coronavirus 2 Isolated from a Human Synthetic Fab Phage Display Library.
    Kim YJ; Lee MH; Lee SR; Chung HY; Kim K; Lee TG; Kim DY
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and affinity optimization of single domain antibody targeting the SARS-CoV-2 nucleocapsid protein.
    Yang Q; Yan M; Lin J; Lu Y; Lin S; Li Z; Wang H; Yang J; Zhang N; Chen X
    PeerJ; 2024; 12():e17846. PubMed ID: 39224822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays.
    Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N;
    Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved diagnosis of SARS-CoV-2 by using nucleoprotein and spike protein fragment 2 in quantitative dual ELISA tests.
    De Marco Verissimo C; O'Brien C; López Corrales J; Dorey A; Cwiklinski K; Lalor R; Doyle JM; Field S; Masterson C; Ribes Martinez E; Hughes G; Bergin C; Walshe K; McNicholas B; Laffey JG; Dalton JP; Kerr C; Doyle S
    Epidemiol Infect; 2021 Jun; 149():e140. PubMed ID: 34099081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation.
    Kang S; Yang M; He S; Wang Y; Chen X; Chen YQ; Hong Z; Liu J; Jiang G; Chen Q; Zhou Z; Zhou Z; Huang Z; Huang X; He H; Zheng W; Liao HX; Xiao F; Shan H; Chen S
    Nat Commun; 2021 May; 12(1):2697. PubMed ID: 33976229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG antibody titers against SARS-CoV-2 nucleocapsid protein correlate with the severity of COVID-19 patients.
    Yang L; Xu Q; Yang B; Li J; Dong R; Da J; Ye Z; Xu Y; Zhou H; Zhang X; Liu L; Zha Y; Yu F
    BMC Microbiol; 2021 Dec; 21(1):351. PubMed ID: 34922455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and utility of a single-chain fragment variable monoclonal antibody platform against a baculovirus expressed recombinant receptor binding domain of SARS-CoV-2 spike protein.
    Salem R; El-Kholy AA; Waly FR; Ayman D; Sakr A; Hussein M
    Mol Immunol; 2022 Jan; 141():287-296. PubMed ID: 34915268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly specific monoclonal antibodies and epitope identification against SARS-CoV-2 nucleocapsid protein for antigen detection tests.
    Yamaoka Y; Miyakawa K; Jeremiah SS; Funabashi R; Okudela K; Kikuchi S; Katada J; Wada A; Takei T; Nishi M; Shimizu K; Ozawa H; Usuku S; Kawakami C; Tanaka N; Morita T; Hayashi H; Mitsui H; Suzuki K; Aizawa D; Yoshimura Y; Miyazaki T; Yamazaki E; Suzuki T; Kimura H; Shimizu H; Okabe N; Hasegawa H; Ryo A
    Cell Rep Med; 2021 Jun; 2(6):100311. PubMed ID: 34027498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.
    Sasson JM; Campo JJ; Carpenter RM; Young MK; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Teng AA; Pablo JV; Liang X; Yee A; Petri WA; Camerini D
    mBio; 2021 Jun; 12(3):e0122921. PubMed ID: 34182775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and Quantitative Detection of Human Antibodies against the 2019 Novel Coronavirus SARS CoV2 and Its Variants as a Result of Vaccination and Infection.
    Taubner B; Peredo-Wende R; Ramani A; Singh G; Strle K; Cady NC
    Microbiol Spectr; 2021 Oct; 9(2):e0089021. PubMed ID: 34585942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity.
    Lee E; Sandgren K; Duette G; Stylianou VV; Khanna R; Eden JS; Blyth E; Gottlieb D; Cunningham AL; Palmer S
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33443088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide microarray-based analysis of antibody responses to SARS-CoV-2 identifies unique epitopes with potential for diagnostic test development.
    Holenya P; Lange PJ; Reimer U; Woltersdorf W; Panterodt T; Glas M; Wasner M; Eckey M; Drosch M; Hollidt JM; Naumann M; Kern F; Wenschuh H; Lange R; Schnatbaum K; Bier FF
    Eur J Immunol; 2021 Jul; 51(7):1839-1849. PubMed ID: 33772767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multiplex Noninvasive Salivary Antibody Assay for SARS-CoV-2 Infection and Its Application in a Population-Based Survey by Mail.
    Egorov AI; Griffin SM; Fuzawa M; Kobylanski J; Grindstaff R; Padgett W; Simmons S; Hallinger DR; Styles JN; Wickersham L; Sams E; Hudgens E; Wade TJ
    Microbiol Spectr; 2021 Oct; 9(2):e0069321. PubMed ID: 34523986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and Development of an Antigen Test for SARS-CoV-2 Nucleocapsid Protein to Validate the Viral Quality Assurance Panels.
    Ray P; Ledgerwood-Lee M; Brickner H; Clark AE; Garretson A; Graham R; Van Zant W; Carlin AF; Aronoff-Spencer ES
    Viruses; 2024 Apr; 16(5):. PubMed ID: 38793544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of highly specific monoclonal antibodies against SARS-CoV-2 nucleocapsid protein and the preliminary development of antigen detection test strips.
    Xie C; Ding H; Ding J; Xue Y; Lu S; Lv H
    J Med Virol; 2022 Apr; 94(4):1633-1640. PubMed ID: 34904253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 10-Minute "Mix and Read" Antibody Assay for SARS-CoV-2.
    Rusanen J; Kareinen L; Levanov L; Mero S; Pakkanen SH; Kantele A; Amanat F; Krammer F; Hedman K; Vapalahti O; Hepojoki J
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33498157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting COVID-19 Severity with a Specific Nucleocapsid Antibody plus Disease Risk Factor Score.
    Sen SR; Sanders EC; Gabriel KN; Miller BM; Isoda HM; Salcedo GS; Garrido JE; Dyer RP; Nakajima R; Jain A; Caldaruse AM; Santos AM; Bhuvan K; Tifrea DF; Ricks-Oddie JL; Felgner PL; Edwards RA; Majumdar S; Weiss GA
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33910993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting intra-viral conserved nucleocapsid (N) proteins as novel vaccines against SARS-CoVs.
    Thura M; Sng JXE; Ang KH; Li J; Gupta A; Hong JM; Hong CW; Zeng Q
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34519332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.